Skip to main content
Scott Irwin, MD, Psychiatry, Los Angeles, CA

Scott A Irwin MD PhD

Psychosomatic Medicine


Director Patient and Family Support Program and Professor of Psychiatry and Behavioral Neurosciences; Cedars-Sinai Health System, Cedars-Sinai Cancer, and Department of Psychiatry and Behavioral Neurosciences

Join to View Full Profile
  • Cedars-Sinai Health System8700 Beverly BlvdLos Angeles, CA 90048

  • Phone+1 310-423-0638

Dr. Irwin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of California (San Diego) Medical Center
    University of California (San Diego) Medical CenterResidency, Psychiatry, 2002 - 2006
  • University of Illinois College of Medicine
    University of Illinois College of MedicineClass of 2002
  • University of Illinois at Urbana-Champaign
    University of Illinois at Urbana-ChampaignPhD, Neuroanatomy, 2000
  • University of California, Los Angeles
    University of California, Los AngelesBS, Psychobiology, 1994

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2003 - 2027
  • Psychiatry
    American Board of Psychiatry and Neurology Psychiatry
  • Consultation-Liaison Psychiatry
    American Board of Psychiatry and Neurology Consultation-Liaison Psychiatry

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2017
  • CMS Meaningful Use Stage 2 Certification Sunquest Laboratory, Sunquest Information Systems, Inc., 2017
  • CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite (with Beaker), Epic Systems Corporation, 2017

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Caregiving at the end-of-life  
    Pottie, C.G., Montross-Thomas, L., Burch, K.A., and Irwin, S.A, Journal of Palliative Medicine, 1/1/2014
  • What did I miss? A qualitative assessment of the impact of patient suicide on hospice clinical staff  
    Fairman N, Montross LP, Whitmore S, Meier E, Irwin SA, Journal of Palliative Medicine, 1/1/2014
  • Association Between Hospice Care and Psychological Outcomes in Alzheimer’s Family Caregivers  
    Irwin, S.A., Mausbach, B.T., Koo, D., Fairman, N., Roepke, S.K., Chattillion, E.A., Dimsdale, J.E., Patterson, T.L., Ancoli-Israel, S., Mills, P.J., von Kanel, R., Zie..., Journal of Palliative Medicine, 1/1/2013

Books/Book Chapters

Abstracts/Posters

  • Hospice Women’s Reflections on Wisdom: A Qualitative Case Series
    Marrone, L., Montross, L., Jeste, D., Irwin, S.A., Holzer, J., Moore, K., Rivas, T., and De Cervantes-Montheith, American Association of Geriatric Psychiatry, 1/1/2014
  • A Retrospective Chart Review of the Use of Ketamine to Treat Depression in Hospice Patients
    Morrison, K., Iglewicz, A., and Irwin, S.A, American Academy of Hospice and Palliative Medicine Annual Meeting, 3/1/2013
  • Ketamine for the Management of Depression in Palliative Care: An Update on the Science
    Irwin, S.A., Hirst, J., Fairman, N., and Prommer E, American Academy of Hospice and Palliative Medicine Annual Meeting, 3/1/2013

Lectures

  • Geriatrics Career Panel 
    La Jolla, CA - 7/30/2014
  • Clinical Challenges with Depression Comorbidities and the Palliative Care Patient 
    Los Angeles, CA - 2/25/2014
  • The Opportunity for Healthcare via Palliative Care 
    San Diego, CA - 1/23/2014

Press Mentions

  • ABVC BioPharma Provides ABV-1601 Update on Phase I Site Initiation Visit Conducted at Cedars-Sinai Medical Center (CSMC)
    ABVC BioPharma Provides ABV-1601 Update on Phase I Site Initiation Visit Conducted at Cedars-Sinai Medical Center (CSMC)April 10th, 2023
  • Cedars-Sinai Medical Center Joins Phase I Clinical Study of ABVC BioPharma’s Medication for Treating Depression in Cancer Patients
    Cedars-Sinai Medical Center Joins Phase I Clinical Study of ABVC BioPharma’s Medication for Treating Depression in Cancer PatientsNovember 2nd, 2022
  • Cedars-Sinai Medical Center Joins Phase I Clinical Study of ABVC BioPharma’s Medication for Treating Depression in Cancer Patients
    Cedars-Sinai Medical Center Joins Phase I Clinical Study of ABVC BioPharma’s Medication for Treating Depression in Cancer PatientsNovember 2nd, 2022

Grant Support

  • Randomized Controlled Trial of Virtual Reality for GI Cancer Pain to Improve Patient Reported OutcomesCEDARS-SINAI MEDICAL CENTER2021–2026
  • Improving Psychiatric Interventions At The END Of LifeNational Institute Of Mental Health2010–2011
  • Expression And Function Of FMRP During DevelopmentNational Institute Of Mental Health1996–2002

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: